-+ 0.00%
-+ 0.00%
-+ 0.00%
ProKidney Promotes Farah Ali to Chief Medical Officer
Share
Listen to the news
ProKidney Promotes Farah Ali to Chief Medical Officer
  • ProKidney promoted Farah Ali to chief medical officer today to lead its clinical program, including the pivotal Phase 3 PROACT 1 rilparencel study.
  • Ali previously served as Immunovant's senior vice president of clinical development, leading programs in endocrinology and rheumatology.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611181615PRIMZONEFULLFEED9880529) on November 18, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending